Clinical Trial Update: A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®

View source ↗

Summary

A clinical trial update indicating ongoing enrollment by invitation for males with Hemophilia A being treated prophylactically with Esperoct (turoctocog alfa pe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Esperoct (turoctocog alfa pegol)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Haemophilia A | Status: ENROLLING_BY_INVITATION